Cargando…
Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities
Autor principal: | Pater, Cornel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549209/ https://www.ncbi.nlm.nih.gov/pubmed/15691384 http://dx.doi.org/10.1186/1468-6708-6-1 |
Ejemplares similares
-
Safety assessment of adjuvanted vaccines: Methodological considerations
por: Da Silva, Fernanda Tavares, et al.
Publicado: (2015) -
Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)
por: Pater, Cornel
Publicado: (2004) -
Drug safety assessment in clinical trials: methodological challenges and opportunities
por: Singh, Sonal, et al.
Publicado: (2012) -
New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery
por: Tang, Yun, et al.
Publicado: (2006) -
Chemical Profiles and Toxicity of Electronic Cigarettes: An Umbrella Review and Methodological Considerations
por: Travis, Nargiz, et al.
Publicado: (2023)